Cargando…
A perspective on SARS-CoV-2 virus-like particles vaccines
Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) first appeared in Wuhan, China, in December 2019. The 2019 coronavirus disease (COVID-19) pandemic, caused by SARS-CoV-2, has spread to almost all corners of the world at an alarming rate. Vaccination is important for the prevention and co...
Autores principales: | Gao, Xiaoyang, Xia, Yeting, Liu, Xiaofang, Xu, Yinlan, Lu, Pengyang, dong, Zhipeng, Liu, Jing, Liang, Gaofeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Published by Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9832101/ https://www.ncbi.nlm.nih.gov/pubmed/36649673 http://dx.doi.org/10.1016/j.intimp.2022.109650 |
Ejemplares similares
-
Nanoparticle and virus-like particle vaccine approaches against SARS-CoV-2
por: Kim, Chulwoo, et al.
Publicado: (2022) -
Design and characterization of chimeric Rabies-SARS-CoV-2 virus-like particles for vaccine purposes
por: Garay, Ernesto, et al.
Publicado: (2023) -
Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like Particles
por: Zha, Lisha, et al.
Publicado: (2021) -
A scalable and highly immunogenic virus‐like particle‐based vaccine against SARS‐CoV‐2
por: Mohsen, Mona O., et al.
Publicado: (2021) -
Virus-like Particle Vaccines and Platforms for Vaccine Development
por: Kheirvari, Milad, et al.
Publicado: (2023)